South Korean biotechnology company developing exosome-based liquid biopsy and diagnostic platforms
South Korean biotechnology company developing exosome-based liquid biopsy and diagnostic platforms. Its technology analyzes blood-derived exosomes, including with SERS and AI, to support early detection of multiple cancers from a single blood sample. The company also offers high-purity exosome isolation products and services for diagnostics, pharmaceutical, and research applications.